|
|
|
|
|
|
|
|
|
|
ecancer.tv
Dr Kunhli Odunsi talks to ecancertv at AACR2016 about his research into courses of immunotherapy against ovarian cancer.
Having established in previous research the link between T cell infiltration of a tumour to improved patient survival, Dr Odunsi has sought to determine an ovarian cancer antigen - in this case NYSEO1 - to prolong patient remission and promote anti-tumour immune response in patients.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.